Korea Investment CORP Increases Stock Position in West Pharmaceutical Services, Inc. $WST

Korea Investment CORP significantly increased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 129.3% during the third quarter, now owning 56,097 shares valued at $14.72 million. Other institutional investors also adjusted their positions in the medical instruments supplier. Analysts have issued a consensus “Buy” rating for WST with an average target price of $314.56, following recent price target adjustments and upgrades. The company reported strong quarterly earnings, surpassing estimates, and declared a quarterly dividend of $0.22 per share.